Retapamulin

DEA Class; Rx

Common Brand Names; Altabax

• Antibacterials, Topical; 
• Pleuromutilin

Topical pleuromutilin antibiotic
Used for treatment of impetigo due to methicillin-susceptible S. aureus and S. pyogenes
Safety in patients younger than 9 months not established

Indicated for impetigo caused by MSSA or Streptococcus pyogenes

—

Not for oral, intranasal, ophthalmic or intravaginal use; efficacy and safety for mucosal surfaces not established

Discontinue if sensitization or severe local irritation develops

Epistaxis reported with use on nasal mucosa

Not evaluated on mucosal surfaces

There are no available data on use in pregnant women to inform any drug associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes

There are no data available on presence of drug in human milk, its effects on breastfed infant or on milk production

Do not apply to more than 100 cm2 in total area.

Do not apply to more than 100 cm2 in total area.

Do not apply to more than 2% total body surface area.

Do not apply to more than 2% total body surface area.

9 to 11 months: Do not apply to more than 2% total body surface area.
1 to 9 months: Safety and efficacy have not been established.

Safety and efficacy have not been established.

Retapamulin

ointment

• 1% (5, 10, 15g tubes)